Dandan, M., Han, J., Mann, S., Kim, R., Li, K., Mohammed, H., . . . Hellerstein, M. (2023). Acetyl-CoA carboxylase inhibitor increases LDL-apoB production rate in NASH with cirrhosis: Prevention by fenofibrate. Elsevier.
Chicago Style (17th ed.) CitationDandan, Mohamad, et al. Acetyl-CoA Carboxylase Inhibitor Increases LDL-apoB Production Rate in NASH with Cirrhosis: Prevention by Fenofibrate. Elsevier, 2023.
MLA (9th ed.) CitationDandan, Mohamad, et al. Acetyl-CoA Carboxylase Inhibitor Increases LDL-apoB Production Rate in NASH with Cirrhosis: Prevention by Fenofibrate. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.